Crescent Biopharma (CBIO) Net Cash Flow (2013 - 2026)
Crescent Biopharma (CBIO) reported Net Cash Flow of -$24.0 million for Q1 2026, down 94.47% year-over-year from -$434.0 million in Q1 2025, and down 130.01% on a QoQ basis from $80.0 million in Q4 2025.
Crescent Biopharma (CBIO) has 14 years of Net Cash Flow data on file, last reported at -$24.0 million in Q1 2026.
- Quarterly Net Cash Flow fell 94.47% year-over-year to -$24.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $166.9 million (up 1133.3% YoY) and the FY2025 annual result came in at $178.6 million, up 674.63% from the prior year.
- Net Cash Flow eased to -$24.0 million in Q1 2026 per CBIO's latest filing, from $80.0 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $130.3 million in Q2 2025 and bottomed at -$24.0 million in Q1 2026.
- The 5-year median for Net Cash Flow is -$8.6 million (2022), against an average of $7.3 million.
- The widest annual swing landed in 2022, when Net Cash Flow tumbled 201.0%; it then surged 1564.52% in 2025.
- Tracing CBIO's Net Cash Flow over 5 years: stood at -$7.9 million in 2022, then advanced by 3.75% to -$7.6 million in 2023, then soared by 556.56% to $34.8 million in 2024, then jumped by 129.99% to $80.0 million in 2025, then sank by 130.01% to -$24.0 million in 2026.
- Per Business Quant, the three latest CBIO Net Cash Flow figures stand at -$24.0 million (Q1 2026), $80.0 million (Q4 2025), and -$19.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - | -23.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.99 Mn |
| Mar 31, 2026 | -23.99 Mn |
| Dec 31, 2025 | 79.96 Mn |
| Dec 31, 2025 | 79.96 Mn |
| Sep 30, 2025 | -19.33 Mn |
| Sep 30, 2025 | -19.33 Mn |
| Jun 30, 2025 | 130.28 Mn |
| Jun 30, 2025 | 130.28 Mn |
| Mar 31, 2025 | -12.34 Mn |
| Mar 31, 2025 | -12.34 Mn |
| Dec 31, 2024 | 34.77 Mn |
| Dec 31, 2024 | 34.77 Mn |
| Jun 30, 2024 | -8.90 Mn |
| Jun 30, 2024 | -8.90 Mn |
| Mar 31, 2024 | -10.51 Mn |
| Mar 31, 2024 | -10.51 Mn |
| Dec 31, 2023 | -7.61 Mn |
| Dec 31, 2023 | -7.61 Mn |
| Sep 30, 2023 | -8.63 Mn |
| Sep 30, 2023 | -8.63 Mn |
| Jun 30, 2023 | -6.97 Mn |
| Jun 30, 2023 | -6.97 Mn |
| Mar 31, 2023 | 17.13 Mn |
| Mar 31, 2023 | 17.13 Mn |
| Dec 31, 2022 | -7.91 Mn |
| Dec 31, 2022 | -7.91 Mn |
| Sep 30, 2022 | -8.62 Mn |
| Sep 30, 2022 | -8.62 Mn |
| Jun 30, 2022 | -16.27 Mn |
| Jun 30, 2022 | -16.27 Mn |
| Mar 31, 2022 | -13.74 Mn |
| Mar 31, 2022 | -13.74 Mn |
| Dec 31, 2021 | -11.67 Mn |
| Dec 31, 2021 | -11.67 Mn |
| Sep 30, 2021 | -16.93 Mn |
| Sep 30, 2021 | -16.93 Mn |
| Jun 30, 2021 | -13.62 Mn |
| Jun 30, 2021 | -13.62 Mn |
| Mar 31, 2021 | -4.56 Mn |
| Mar 31, 2021 | -4.56 Mn |
| Dec 31, 2020 | -5.84 Mn |
| Dec 31, 2020 | -5.84 Mn |
| Sep 30, 2020 | -6.97 Mn |
| Sep 30, 2020 | -6.97 Mn |
| Jun 30, 2020 | -4.98 Mn |
| Jun 30, 2020 | -4.98 Mn |
| Mar 31, 2020 | -3.38 Mn |
| Mar 31, 2020 | -3.38 Mn |
| Dec 31, 2019 | -12.69 Mn |
| Dec 31, 2019 | -12.69 Mn |
| Sep 30, 2019 | -13.28 Mn |
| Sep 30, 2019 | -13.28 Mn |
| Jun 30, 2019 | -11.39 Mn |
| Jun 30, 2019 | -11.39 Mn |
| Mar 31, 2019 | -14.36 Mn |
| Mar 31, 2019 | -14.36 Mn |
| Dec 31, 2018 | -9.91 Mn |
| Dec 31, 2018 | -9.91 Mn |
| Sep 30, 2018 | -9.61 Mn |
| Sep 30, 2018 | -9.61 Mn |
| Jun 30, 2018 | -13.20 Mn |
| Jun 30, 2018 | -13.20 Mn |
| Mar 31, 2018 | 118.71 Mn |
| Mar 31, 2018 | 118.71 Mn |
| Dec 31, 2017 | 11.05 Mn |
| Dec 31, 2017 | 11.05 Mn |
| Sep 30, 2017 | -6.28 Mn |
| Sep 30, 2017 | -6.28 Mn |
| Jun 30, 2017 | 84.56 Mn |
| Jun 30, 2017 | 84.56 Mn |
| Mar 31, 2017 | -5.45 Mn |
| Mar 31, 2017 | -5.45 Mn |
| Dec 31, 2016 | -5.24 Mn |
| Dec 31, 2016 | -5.24 Mn |
| Sep 30, 2016 | -7.80 Mn |
| Sep 30, 2016 | -7.80 Mn |
| Jun 30, 2016 | 14.26 Mn |
| Jun 30, 2016 | 14.26 Mn |
| Mar 31, 2016 | -7.97 Mn |
| Mar 31, 2016 | -7.97 Mn |
| Dec 31, 2015 | -6.96 Mn |
| Dec 31, 2015 | -6.96 Mn |
| Sep 30, 2015 | 13.53 Mn |
| Sep 30, 2015 | 13.53 Mn |
| Jun 30, 2015 | -6.33 Mn |
| Jun 30, 2015 | -6.33 Mn |
| Mar 31, 2015 | -8.63 Mn |
| Mar 31, 2015 | -8.63 Mn |
| Dec 31, 2014 | -6.16 Mn |
| Dec 31, 2014 | -6.16 Mn |
| Sep 30, 2014 | -4.86 Mn |
| Sep 30, 2014 | -4.86 Mn |
| Jun 30, 2014 | 9.25 Mn |
| Jun 30, 2014 | 9.25 Mn |
| Mar 31, 2014 | 54.66 Mn |
| Mar 31, 2014 | 54.66 Mn |
| Dec 31, 2013 | -5.38 Mn |
| Dec 31, 2013 | -5.38 Mn |
| Sep 30, 2013 | -3.09 Mn |
| Sep 30, 2013 | -3.09 Mn |
| Jun 30, 2013 | -2.73 Mn |
| Jun 30, 2013 | -2.73 Mn |
| Mar 31, 2013 | -3.88 Mn |
| Mar 31, 2013 | -3.88 Mn |